Shigehiro Asano

832 total citations
24 papers, 694 citations indexed

About

Shigehiro Asano is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Shigehiro Asano has authored 24 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Shigehiro Asano's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Chemical Synthesis and Analysis (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Shigehiro Asano is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Chemical Synthesis and Analysis (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Shigehiro Asano collaborates with scholars based in Japan and United States. Shigehiro Asano's co-authors include Carlos F. Barbas, Narihiro Toda, James T Patterson, Yoshiaki Isobe, Thomas Gaj, Daisuke Uemura, Hirokazu Arimoto, Christoph Rader, Takayuki Ishii and Xiuling Li and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Shigehiro Asano

24 papers receiving 678 citations

Peers

Countries citing papers authored by Shigehiro Asano

Since Specialization

Citations

This map shows the geographic impact of Shigehiro Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Asano more than expected).

Fields of papers citing papers by Shigehiro Asano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Asano. The network helps show where Shigehiro Asano may publish in the future.

Co-authorship network of co-authors of Shigehiro Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Asano. A scholar is included among the top collaborators of Shigehiro Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Asano. Shigehiro Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intellectual Property in the Field of Regenerative Medicine in Japan 2018 ·Clinical Therapeutics ·Shigehiro Asano, Yoichi Nakanishi, Daisuke Sugiyama	1
2	Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation 2016 ·Bioconjugate Chemistry ·James T Patterson, (unknown), Shigehiro Asano, (unknown), Roberta Fuller, William Roush, Christoph Rader, Carlos F. Barbas	18
3	Site‐Selective Labeling of a Lysine Residue in Human Serum Albumin 2014 ·Angewandte Chemie ·Shigehiro Asano, James T Patterson, Thomas Gaj, Carlos F. Barbas	14
4	Site‐Selective Labeling of a Lysine Residue in Human Serum Albumin 2014 ·Angewandte Chemie International Edition ·Shigehiro Asano, James T Patterson, Thomas Gaj, Carlos F. Barbas	71
5	Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts 2014 ·ACS Medicinal Chemistry Letters ·Manabu Watanabe, (unknown), Hideyuki Tomizawa, (unknown), (unknown), Yoshiaki Isobe, Shigehiro Asano	22
6	Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers 2014 ·Bioconjugate Chemistry ·James T Patterson, Shigehiro Asano, Xiuling Li, Christoph Rader, Carlos F. Barbas	69
7	Crystal Structures and Structure–Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors 2014 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Tomoyuki Tanaka, (unknown), Yosuke Ota, Takayuki Ishii, (unknown), Shigehiro Asano, Yoshiaki Isobe	122
8	Rapid, Stable, Chemoselective Labeling of Thiols with Julia–Kocieński‐like Reagents: A Serum‐Stable Alternative to Maleimide‐Based Protein Conjugation 2013 ·Angewandte Chemie International Edition ·Narihiro Toda, Shigehiro Asano, Carlos F. Barbas	171
9	Synthesis of Novel Benzo-Fused Heteroaryl Derivatives as Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase II Inhibitors 2013 ·Chemical and Pharmaceutical Bulletin ·(unknown), Shigehiro Asano, (unknown), (unknown), (unknown), Shogo Nakatani, Yoshiaki Isobe	8
10	Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor 2012 ·Bioorganic & Medicinal Chemistry ·(unknown), Shigehiro Asano, (unknown), (unknown), (unknown), Shogo Nakatani, Yoshiaki Isobe	8
11	Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Shigehiro Asano, (unknown), (unknown), (unknown), Shogo Nakatani, Yoshiaki Isobe	4
12	Suzuki–Miyaura cross-coupling reaction of aryl and heteroaryl pinacol boronates for the synthesis of 2-substituted pyrimidines 2011 ·Tetrahedron ·Shigehiro Asano, (unknown), Yoshiaki Isobe	18
13	5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Shigehiro Asano, (unknown), (unknown), (unknown), Shogo Nakatani, Yoshiaki Isobe	12
14	Synthesis and structure–activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N’-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents 2009 ·Bioorganic & Medicinal Chemistry ·Shigehiro Asano, Hitoshi Ban, (unknown), (unknown), (unknown)	1
15	Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: Dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression 2009 ·Bioorganic & Medicinal Chemistry Letters ·Shigehiro Asano, Hitoshi Ban, (unknown), (unknown), (unknown)	6
16	A Convenient One-Pot Preparation of N-Substituted 4-Phenylpiperidines 2008 ·Heterocycles ·Hitoshi Ban, Shigehiro Asano	2
17	Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Naoto Kusunose, Katsuya Fujita, Hideshi Sato, Shigehiro Asano, (unknown), Masaharu Kanaoka	12
18	Synthesis of pinnaic acid; Asymmetric construction of spirocyclic core 1999 ·Tetrahedron Letters ·Hirokazu Arimoto, Shigehiro Asano, Daisuke Uemura	43
19	Total synthesis of allixin; an anti-tumor promoter from garlic 1997 ·Tetrahedron Letters ·Hirokazu Arimoto, Shigehiro Asano, Daisuke Uemura	6
20	Preliminary X-ray data for a d-amino acid amino-transferase from a novel thermophilic Bacillus 1987 ·Journal of Molecular Biology ·Barry Stoddard, (unknown), Shigehiro Asano, Kenji Soda, Katsuyuki Tanizawa, Dagmar Ringe, Gregory A. Petsko	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact